Loading...
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome
IMPORTANCE: Oral propranolol is widely considered to be first-line therapy for complicated infantile hemangioma, but its use in patients with PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome has been debated owing to concerns that the car...
Na minha lista:
| Udgivet i: | JAMA Dermatol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Medical Association
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6990697/ https://ncbi.nlm.nih.gov/pubmed/31825455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2019.3839 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|